{"organizations": [], "uuid": "604c989a0c6e9f958fc47b9157ba3528638d60f4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://odreport.com/feed/", "section_title": "The Overdose Report", "url": "https://www.reuters.com/article/us-health-gabapentins-usa-pain/neurontin-prescriptions-surge-amid-opioid-crisis-idUSKBN1ET261&", "country": "US", "domain_rank": 408, "title": "Neurontin prescriptions surge amid opioid crisis", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-01-04T20:33:00.000+02:00", "replies_count": 0, "uuid": "604c989a0c6e9f958fc47b9157ba3528638d60f4"}, "author": "", "url": "https://www.reuters.com/article/us-health-gabapentins-usa-pain/neurontin-prescriptions-surge-amid-opioid-crisis-idUSKBN1ET261&", "ord_in_thread": 0, "title": "Neurontin prescriptions surge amid opioid crisis", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " ", "external_links": [], "published": "2018-01-04T20:33:00.000+02:00", "crawled": "2018-01-04T22:00:19.081+02:00", "highlightTitle": ""}